Skip to main content
. 2017 Dec 12;2017:6212910. doi: 10.1155/2017/6212910

Table 3.

Univariate analysis for predictors of mortality caused by bloodstream infections with Enterobacteriaceae.

Clinical characteristics Bloodstream infections with Enterobacteriaceae, n (%) P value
Survival group (n = 110) Mortality group (n = 38)
Gender (male) 55 (50.0) 20 (52.6) 0.780
Age 67.5 ± 20.0 73.9 ± 15.9 0.075
Community acquired 28 (25.5) 2 (5.3) 0.008
Admission to the ICU 10 (9.1) 20 (52.6) <0.001
Long-term bedbound 50 (45.5) 30 (78.9) <0.001
Medical institution admission history within 3 months 69 (62.7) 23 (60.5) 0.809
Underlying diseases
 Cardiovascular disease 51 (46.4) 22 (57.9) 0.220
 Cerebrovascular disease 54 (49.1) 24 (63.2) 0.134
 Chronic respiratory disease 12 (10.9) 3 (7.9) 0.827
 Chronic kidney disease 30 (27.3) 16 (42.1) 0.089
 Diabetes mellitus 38 (34.5) 15 (39.5) 0.585
 Malignant tumor 37 (33.6) 11 (28.9) 0.594
 Anemia 77 (70.0) 36 (94.7) 0.002
 Hypoalbuminemia 87 (79.1) 37 (97.4) 0.008
 Lung infection 53 (48.2) 30 (78.9) 0.001
 Urinary tract infection 60 (54.5) 14 (36.8) 0.060
 Abdominal infection 9 (8.2) 10 (26.3) 0.009
 Tracheotomy 22 (20.0) 11 (28.9) 0.253
 Liver dysfunction 20 (18.2) 17 (44.7) 0.001
Invasive surgery before infection
 Mechanic ventilation 10 (9.1) 20 (52.6) <0.001
 Central venous catheterization 20 (18.2) 27 (71.1) <0.001
 Indwelling urethral catheterization 41 (37.3) 29 (76.3) <0.001
Sources of bloodstream infection
 Catheter related 19 (17.3) 14 (36.8) 0.012
 Respiratory system 25 (22.7) 12 (31.6) 0.277
 Urinary tract 39 (35.5) 3 (7.9) 0.001
 Others 27 (24.5) 9 (23.7) 0.915
Prior use of broad-spectrum antibiotics within 30 days 36 (32.7) 28 (73.7) <0.001
Combined fungal infection 9 (8.2) 11 (28.9) <0.001
Prior use of glucocorticoids within 30 days 4 (3.6) 15 (39.5) 0.007
CRE infection 9 (8.2) 17 (44.7) <0.001
Total length of hospital stay 21.4 ± 13.2 22.7 ± 10.4 0.528

CRE: carbapenem-resistant Enterobacteriaceae; P < 0.05.